AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 63 filers reported holding AMRYT PHARMA PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,280,000 | +5.5% | 3,600,000 | 0.0% | 1.15% | -8.7% |
| Q3 2022 | $24,912,000 | -1.0% | 3,600,000 | 0.0% | 1.26% | -5.1% |
| Q2 2022 | $25,164,000 | -15.5% | 3,600,000 | 0.0% | 1.32% | +22.7% |
| Q1 2022 | $29,772,000 | -22.2% | 3,600,000 | +1.6% | 1.08% | -40.5% |
| Q4 2021 | $38,280,000 | -2.4% | 3,544,468 | +8.8% | 1.81% | +64.9% |
| Q3 2021 | $39,231,000 | – | 3,257,005 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |